Trial Outcomes & Findings for Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot Study (NCT NCT00554996)
NCT ID: NCT00554996
Last Updated: 2015-10-16
Results Overview
Rate of UTI during colonization with E. coli 83972.
Recruitment status
COMPLETED
Study phase
PHASE1
Target enrollment
10 participants
Primary outcome timeframe
0-266 days of colonization
Results posted on
2015-10-16
Participant Flow
Participant milestones
| Measure |
E. Coli 83972 Coated Urinary Catheter
E. coli 83972 coated urinary catheter: E. coli 83972 coated urinary catheter
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Bacterial Interference for Prevention of Catheter-Associated UTI: Geriatric Pilot Study
Baseline characteristics by cohort
| Measure |
E. Coli 83972 Coated Urinary Catheter
n=10 Participants
E. coli 83972 coated urinary catheter: E. coli 83972 coated urinary catheter
|
|---|---|
|
Age, Continuous
|
70.9 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 0-266 days of colonizationPopulation: Number of UTIs per 1000 patient-days during colonization with E. coli 83972.
Rate of UTI during colonization with E. coli 83972.
Outcome measures
| Measure |
E. Coli 83972 Coated Urinary Catheter
n=10 Participants
E. coli 83972 coated urinary catheter: E. coli 83972 coated urinary catheter
|
|---|---|
|
Rate of UTI While Colonized With E. Coli 83972.
|
8.5 UTIs per 1000 patient-days
|
Adverse Events
E. Coli 83972 Coated Urinary Catheter
Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
E. Coli 83972 Coated Urinary Catheter
n=10 participants at risk
E. coli 83972 coated urinary catheter: E. coli 83972 coated urinary catheter
|
|---|---|
|
Renal and urinary disorders
Febrile UTI or Urosepsis/bacteremia
|
50.0%
5/10 • Number of events 5
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place